Cargando…

1090. HHV-6 Encephalitis following Chimeric Antigen Receptor T-cell Therapy: Report of 2 Cases

BACKGROUND: Human herpesvirus 6 (HHV-6) is the most common cause of infectious encephalitis following hematopoietic stem cell transplant. Chimeric antigen receptor T-cell (CAR-T) therapy is a novel cancer-directed immunotherapy; chemotherapy conditioning for CAR-T results in prolonged, severe immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebechi, Melanie T, Bork, Jacqueline, Riedel, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776148/ http://dx.doi.org/10.1093/ofid/ofaa439.1276

Ejemplares similares

HHV-6 Encephalitis After Chimeric Antigen Receptor T-cell Therapy (CAR-T): 2 Case Reports and a Brief Review of the Literature
por: Rebechi, Melanie T, et al.
Publicado: (2021)

266. A Rare Case of Human Herpesvirus-6 (HHV-6) Encephalitis in an Immunocompetent Host
por: Ayyash, Ali M, et al.
Publicado: (2021)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy
por: Trottier, Caitlin, et al.
Publicado: (2021)

578. Infections in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) therapy
por: Tran, Nikki, et al.
Publicado: (2020)

HHV-6 DNA in CSF and diagnosis of encephalitis
por: Ward, K.N., et al.
Publicado: (2006)

Learning More About HHV-6 Encephalitis
por: Berger, Joseph R.
Publicado: (2021)

2711. Viral encephalitis after chimeric antigen receptor (CAR)-modified T-cell therapy: A Retrospective Cohort Study
por: Kampouri, Eleftheria, et al.
Publicado: (2023)

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.
por: Le Gouill, Steven, et al.
Publicado: (2023)

1994. Infections following Chimeric Antigen Receptor (CAR) – T cell Therapy: 2018-2022
por: Keri, Vishakh C, et al.
Publicado: (2023)

1098. Norovirus Infection in Cancer Patients Undergoing Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T)
por: Kondapi, Divya S, et al.
Publicado: (2020)

“Unspecified organic personality and behavioral disorder due to brain damage from HHV-6 encephalitis in child. case report and literature review”
por: Oliva Lozano, A., et al.
Publicado: (2023)

1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
por: Garner, Will, et al.
Publicado: (2020)

Clinical, radiological, and electroencephalographic features of HHV-6 encephalitis following hematopoietic stem cell transplantation
por: Yassin, Ahmed, et al.
Publicado: (2020)

A rare case of recurrent HHV6 encephalitis in an immunocompetent adult
por: Al-Asmar, Rania, et al.
Publicado: (2021)

Progressive Developments from 1090 Onwards
Publicado: (1918)

Human Herpesvirus 6 (HHV-6) Encephalitis in a Non-Transplant Patient With Polymyositis
por: Baleguli, Vidya, et al.
Publicado: (2021)

IRAK4 Deficiency Presenting with Anti-NMDAR Encephalitis and HHV6 Reactivation
por: Nishimura, Shiho, et al.
Publicado: (2020)

1090. Practicing Antimicrobial Stewardship: De-escalating Empiric Antibiotics in Patients with Acute Myelogenous Leukemia and Neutropenic Fever
por: Fuller, Risa, et al.
Publicado: (2019)

2718. Prevalence of Infections Following Anti-CD30 Targeted Chimeric Antigen Receptor T-cell Therapy for Relapsed and Refractory Lymphoma
por: Mohnasky, Michael C, et al.
Publicado: (2023)

1090. Patient Outcomes With Prevented vs. Negative Clostridium difficile Tests Using Computerized Clinical Decision Support (CCDS)
por: Madden, Gregory, et al.
Publicado: (2018)

HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient
por: Voigt, Margarete, et al.
Publicado: (2021)

The role of HHV-6 and HHV-7 infections in the development of fibromyalgia
por: Krumina, Angelika, et al.
Publicado: (2019)

DNA Sensors’ Signaling in NK Cells During HHV-6A, HHV-6B and HHV-7 Infection
por: Bortolotti, Daria, et al.
Publicado: (2020)

1090. Factors effecting mortality among Covid-19 patients in Renal Transplant Recipients from a single center in Pakistan
por: Nasim, Asma, et al.
Publicado: (2022)

Thrombotic microangiopathy following chimeric antigen receptor T-cell therapy
por: Wu, Matthew S., et al.
Publicado: (2023)

Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
por: Tschernia, Nicholas, et al.
Publicado: (2014)

Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023)

Status Epilepticus due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
por: Chordia, Poorvi, et al.
Publicado: (2014)

A Rare Case of HHV-6 Encephalitis in an Immunocompetent Host: Case Report and Literature Review
por: Mekheal, Erinie, et al.
Publicado: (2022)

Seroprevalence of HHV-6 and HHV-8 among blood donors in Greece
por: Politou, Marianna, et al.
Publicado: (2014)

Evolutionary analysis of exogenous and integrated HHV-6A/HHV-6B populations
por: Forni, Diego, et al.
Publicado: (2020)

A complex evolutionary relationship between HHV-6A and HHV-6B
por: Forni, Diego, et al.
Publicado: (2019)

P1236: EFFICACY AND TOXICITY FOR CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY T-CELL LYMPHOMA
por: Hu, K., et al.
Publicado: (2022)

P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHIMERIC ANTIGEN RECEPTOR THERAPIES, POLATUZUMAB-BASED REGIMENS, AND TAFASITAMAB-BASED REGIMENS
por: Rosenthal, Allison, et al.
Publicado: (2023)

Development of chimeric antigen receptor-redirected T cell therapy targeting L1-CAM in ovarian cancer
por: Hong, Hao, et al.
Publicado: (2013)

Intravascular clusters of T cells following chimeric antigen receptor T cell therapy
por: Nakamura, Naokazu, et al.
Publicado: (2022)

HHV-6 and Multiple Sclerosis
por: Jeanne Billioux, Bridgette, et al.
Publicado: (2014)

Retraction to: A complex evolutionary relationship between HHV-6A and HHV-6B
por: Forni, Diego, et al.
Publicado: (2019)

A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target
por: Santoro, Stephen P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_968kbmrr26h4e5fcjda8h38m2f